Holen Sie sich die Stockscreener-App
9.075
3.04%
-0.285
Handel nachbörslich:
9.07
-0.005
-0.06%
Schlusskurs vom Vortag:
$9.36
Offen:
$9.47
24-Stunden-Volumen:
105.29K
Relative Volume:
0.68
Marktkapitalisierung:
$119.36M
Einnahmen:
$1.93M
Nettoeinkommen (Verlust:
$-7.96M
KGV:
-0.00257
EPS:
-3530.8178
Netto-Cashflow:
$-36.78M
1W Leistung:
+9.21%
1M Leistung:
+89.85%
6M Leistung:
+17.40%
1J Leistung:
-8.15%
1-Tages-Spanne:
$8.93
$9.70
1-Wochen-Bereich:
$8.0101
$9.88
52-Wochen-Spanne:
$3.39
$16.00
Avalo Therapeutics Inc Stock (AVTX) Company Profile
Firmenname
Avalo Therapeutics Inc
Sektor
Branche
Telefon
410-522-8707
Adresse
1500 LIBERTY RIDGE DRIVE, WAYNE
Vergleichen Sie AVTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
9.075 | 97.50M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-03-25 | Eingeleitet | Jefferies | Buy |
| 2025-03-25 | Eingeleitet | Stifel | Buy |
| 2025-02-28 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-21 | Eingeleitet | Wedbush | Outperform |
| 2024-12-19 | Eingeleitet | BTIG Research | Buy |
| 2024-10-24 | Eingeleitet | H.C. Wainwright | Neutral |
| 2024-04-16 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-09-24 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Avalo Therapeutics Inc Aktie (AVTX) Neueste Nachrichten
Avalo Therapeutics Reports Q2 2025 Financial Results - MSN
Avalo Therapeutics Inc.’s Beta Climbs After Market VolatilityEarnings Trend Report & Weekly Market Pulse Updates - 선데이타임즈
Avalo Therapeutics Inc. stock outlook for YEARWeekly Profit Recap & Verified Momentum Stock Watchlist - Newser
News impact scoring models applied to Avalo Therapeutics Inc.Market Volume Summary & AI Enhanced Trading Alerts - Newser
What institutions are buying Avalo Therapeutics Inc. stock nowJuly 2025 Analyst Calls & Free Accurate Trade Setup Notifications - Newser
Quantitative breakdown of Avalo Therapeutics Inc. recent move2025 Market Outlook & Fast Entry and Exit Trade Plans - Newser
Chart based exit strategy for Avalo Therapeutics Inc.Capital Protection Strategy With Risk Analysis - Newser
Using RSI to spot recovery in Avalo Therapeutics Inc.Weekly Hot Stocks Based on Volume Flow - Newser
Why Avalo Therapeutics Inc. stock attracts strong analyst attentionIntraday Signal Forecast for Fast Traders - Newser
Should you wait for a breakout in Avalo Therapeutics Inc.Free Conservative Entry for High Return Setup - Newser
Custom strategy builders for tracking Avalo Therapeutics Inc.Trade Plan With Low Risk High Return - Newser
How to track smart money flows in Avalo Therapeutics Inc.Free Smart Trend Trading with Weekly Signals - Newser
Avalo Therapeutics Inc. stock chart pattern explainedFree Capital Preserving Trade Plan Templates - Newser
Avalo Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Is Avalo Therapeutics Inc. forming a reversal patternFree Buy Signal Based on Chart Analysis - Newser
Can Avalo Therapeutics Inc. recover in the next quarterWatchlist Generator With Real-Time Entry - Newser
Will a bounce in Avalo Therapeutics Inc. offer an exitMarket Timing Strategy with Technical Filters - Newser
Is Avalo Therapeutics Inc. reversing from oversold territoryChart Driven Opportunity Scanner with Alerts - Newser
How to forecast Avalo Therapeutics Inc. trends using time seriesFree Intraday Trend Analysis for Fast Gains - Newser
Risk vs reward if holding onto Avalo Therapeutics Inc.Buy Point Strategy with Profit Protection - Newser
Can swing trading help recover from Avalo Therapeutics Inc. lossesLong Term Stock Planner with Safety Checks - Newser
Pattern recognition hints at Avalo Therapeutics Inc. upsideFree AI Screening for Swing Trade Picks - Newser
Buy Signal for Avalo Therapeutics Inc. Stock Key Technical Indicators to WatchIntraday Signal Forecast for Fast Traders - Newser
Avalo Therapeutics: Promising Phase 2 Trial and Market Opportunities Drive Buy Rating - TipRanks
Does Avalo Therapeutics Inc. stock pay reliable dividendsPrice Forecast Based on AI Analysis - Newser
What momentum shifts mean for Avalo Therapeutics Inc.AI Volatility Forecast and Risk Monitor - Newser
Avalo Reports Second Quarter 2025 Financial Results and Recent Business Updates - GlobeNewswire
Risk adjusted return profile for Avalo Therapeutics Inc. analyzed [July 2025 Action]High Accuracy Trade Alerts - Newser
Avalo Therapeutics (AVTX) up more than 100% since Jul 11 - AInvest
Finanzdaten der Avalo Therapeutics Inc-Aktie (AVTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):